Otello Stampacchia

Affiliations

  • Large Shareholder at Lexeo Therapeutics Inc. (LXEO), 2023-11-10
  • Director at Ikena Oncology Inc. (IKNA), 2023-06-13
  • Director at Kronos Bio Inc. (KRON), 2022-06-29
  • Large Shareholder at Replimune Group Inc. (REPL), 2022-03-17
  • Other at Theseus Pharmaceuticals Inc. (THRX), 2021-10-14
  • Director at Morphic Holding Inc. (MORF), 2021-05-03
  • Large Shareholder at Nuvation Bio Inc. (NUVB), 2021-02-12
  • Chief Executive Officer at Omega Alpha Spac (OMEG), 2021-01-13
  • Large Shareholder, Other at Gossamer Bio Inc. (GOSS), 2019-09-18
  • Large Shareholder at Immunic Inc. (IMUX), 2019-04-22
  • Large Shareholder at Translate Bio Inc. (TBIO), 2018-07-03
  • Other at Kezar Life Sciences Inc. (KZR), 2018-06-25
  • Large Shareholder at Paratek Pharmaceuticals Inc. (PRTK), 2014-11-10
  • Director at Micromet Inc. (MITI), 2010-03-04
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
OMEG $10.00 501,000 Large Shareholder, Officer, Director 501,000 2021-01-11 Filing
KRON $19.00 450,000 Large Shareholder, Director 3,818,283 2020-10-14 Filing
MORF $15.00 133,333 Large Shareholder, Director 2,969,582 2019-07-01 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MITI $8.04 55,000 Director 2,197,413 2010-03-04 Filing
MITI $8.19 108,000 Director 2,252,413 2010-03-03 Filing
MITI $8.03 52,000 Director 2,360,413 2010-03-02 Filing
MITI $8.00 2,000 Director 2,412,413 2010-02-19 Filing
MITI $8.03 25,000 Director 2,414,413 2010-02-18 Filing